Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pearson

Showing results (331-340 of 360) with videos related to

Pageof 36
Sort By:
Current Topics in Medicinal Chemistry|February 3, 2004
Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticityE Sher, Y Chen, T J W Sharples, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2006
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiatorsLisa M Broad, Ruud Zwart, Kathy H Pearson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
The association of physical activity and body mass index with the risk of large bowel polypsKristin Wallace, John A Baron, Margaret R Karagas, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
European Journal of Pharmacology|April 8, 2003
Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 propertiesNon M Evans, Suchira Bose, Giovanni Benedetti, et al.
Surgery|October 1, 1990
Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancerJ P Crowe, N H Gordon, R R Shenk, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Current Surgery|January 1, 1984
The prognostic importance of estrogen receptor level for Stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Radiology|October 29, 2008
Lumbar spine: reliability of MR imaging findingsJohn A Carrino, Jon D Lurie, Anna N A Tosteson, et al.
Pageof 36

Showing results (331-340 of 360) with videos related to

Sort By:
Pageof 36
Current Topics in Medicinal Chemistry|February 3, 2004
Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticityE Sher, Y Chen, T J W Sharples, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 2, 2006
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiatorsLisa M Broad, Ruud Zwart, Kathy H Pearson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 21, 2005
The association of physical activity and body mass index with the risk of large bowel polypsKristin Wallace, John A Baron, Margaret R Karagas, et al.
Breast Cancer Research and Treatment|January 1, 1982
Estrogen receptor status as a prognostic indicator for stage I breast cancer patientsJ P Crowe, C A Hubay, O H Pearson, et al.
European Journal of Pharmacology|April 8, 2003
Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 propertiesNon M Evans, Suchira Bose, Giovanni Benedetti, et al.
Surgery|October 1, 1990
Short-term tamoxifen plus chemotherapy: superior results in node-positive breast cancerJ P Crowe, N H Gordon, R R Shenk, et al.
Breast Cancer Research and Treatment|January 1, 1983
Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: five-year resultsO H Pearson, C A Hubay, J S Marshall, et al.
Current Surgery|January 1, 1984
The prognostic importance of estrogen receptor level for Stage I breast cancer patientsJ P Crowe, N H Gordon, C A Hubay, et al.
Surgery|July 1, 1984
Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-upC A Hubay, N H Gordon, J P Crowe, et al.
Radiology|October 29, 2008
Lumbar spine: reliability of MR imaging findingsJohn A Carrino, Jon D Lurie, Anna N A Tosteson, et al.
Pageof 36